• Patients on Anticoagulant Therapy With and Without Hematoma Enlargement
  • Chronic Care Anticoagulant Therapy Management
  • Warfarin Dosage in Anticoagulant Chronic Care Management
  • Chronic Disease Management and Patient Outcomes
  • Thrombolysis Treatment for Pulmonary Embolism Complications


  • Anticoagulant Therapy
  • Hematoma Treatment
  • Novel Anticoagulants
  • Chronic Care Model
  • Chronic Disease Management
  • Wagner Chronic Care Model
  • Thrombolytics
  • Treatment of Pulmonary Embolism
  • Warfarin Monitoring
  • Clotting Factors

Anticoagulation Therapy Outcomes Data Package

$1,074 $750 / YEAR

This data package is about anticoagulant therapy. It includes following datasets: patients with and without hematoma enlargement, chronic care management differences and patient outcomes in anticoagulant clinics, participant characteristics anticoagulants randomized trial, pulmonary embolism thrombolysis treatment and its complications.

Anticoagulation therapy is used for study purposes. - To examine the utilization of anticoagulation services. - Anticoagulation is an essential lifesaving management practice indicated for arterial, venous and intracardiac thromboembolism.
1. Characteristics of OAC Patients With and Without Hematoma Enlargement ($179)
2. Chronic Care Management Differences in Anticoagulant Clinics ($179)
3. Chronic Care Management Patient Outcomes in Anticoagulant Regions ($179)
4. Participant Characteristics Anticoagulants Randomized Trial JAMA ($179)
5. Pulmonary Embolism Thrombolysis Treatment and Its Complications JAMA ($179)
6. Subgroup Analysis for Mode of Reversal Treatment FFP vs PCC ($179)